Introduction
============

Cataracts are generally treated surgically; however, excess proliferation and differentiation of the remaining human lens epithelial cells (HLECs) may result in vision disturbance following surgery ([@b1-mmr-21-01-0173]--[@b3-mmr-21-01-0173]). Epithelial-to-mesenchymal transition (EMT) has been implicated in the transition of HLECs to myofibroblasts ([@b4-mmr-21-01-0173],[@b5-mmr-21-01-0173]).

EMT cell characteristics include the acquisition of a spindle-shaped morphology that is accompanied by an accumulation of α-smooth muscle actin (α-SMA), a redistribution of actin stress fibers, a loss of cell polarity and epithelial markers such as cytokeratin, zonula occludens-1 and epithelial cadherin (E-cadherin), and upregulation of transcription factors including snail family transcriptional repressor 1 and 2 and twist family bHLH transcription factor 1 ([@b6-mmr-21-01-0173]--[@b11-mmr-21-01-0173]).

Previous studies have revealed that cataract surgery may result in cellular stress ([@b12-mmr-21-01-0173],[@b13-mmr-21-01-0173]). The endoplasmic reticulum (ER) serves an important role in detecting cellular stress, and subsequently triggers the ER stress response (ER stress) to restore cellular homeostasis. Additionally, the unfolded protein response (UPR) is triggered alongside ER stress to additionally decrease cellular stress ([@b14-mmr-21-01-0173]).

Evidence indicates that the UPR participates in crosstalk with EMT in several types of cells: The UPR potentiates EMT in gastric cancer cells under conditions of severe hypoxia ([@b15-mmr-21-01-0173]) or prolonged ER stress, and results in irreversible EMT in human peritoneal mesothelial cells ([@b16-mmr-21-01-0173]). However, whether ER stress affects EMT in the human lens epithelium remains unclear. Therefore, the present study evaluated the role of ER stress in inducing EMT in HLECs. ER stress resulted in morphological changes, increased cell migration and altered expression of EMT-associated proteins in a human lens epithelial cell line *in vitro*. Together, these results suggested that ER stress serves an important role in regulating EMT in HLECs.

Materials and methods
=====================

### Reagents and antibodies

The ER stress activators thapsigargin (TG) and tunicamycin (TM) were purchased from Sigma-Aldrich; Merck KGaA and Beijing Solarbio Science & Technology Co., Ltd., respectively. The ER stress inhibitors 4-phenylbutyric acid (PBA) and sodium tauroursodeoxycholate (TUDCA) were purchased from Sigma-Aldrich; Merck KGaA. TM, TG, PBA and TUDCA were dissolved in dimethyl sulfoxide (DMSO; Leagene). Anti-glucose-regulated protein 78 kDa (GRP78; ab12223), anti-activating transcription factor (ATF)6 (ab11909), anti-phosphorylated eukaryotic initiation factor 2α (p-IRE1α; ab48187), anti-E-Cadherin (ab40772), anti-fibronectin (ab2413) and anti-α-SMA (ab32575) primary antibodies were purchased from Abcam. Horseradish peroxidase-conjugated anti-p-eIF2α (119A11), horse anti-mouse and horse anti-rabbit secondary antibodies, Alexa Fluor 488-conjugated goat anti-rabbit and Alexa Fluor 488-conjugated goat anti-mouse secondary antibodies were purchased from Cell Signaling Technology, Inc. Anti-ATF4 primary antibody (sc-390063) was purchased from Santa Cruz Biotechnology, Inc. Primary antibodies against vimentin (10366-1-AP), β-actin (66009-1-Ig) and Neural cadherin (N-cadherin; 22018-1-AP) were purchased from ProteinTech Group, Inc.

### HLEC culture and treatment

The human lens epithelial SRA01/04 cell line (supplied by Professor Shang, Zhongshan Ophthalmic Center) was cultured in Dulbecco\'s modified Eagle\'s medium (Gibco; Thermo Fisher Scientific, Inc.) supplemented with 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) and 1% penicillin/streptomycin at 37°C. In order to evaluate the role of ER stress, SRA01/04 cells were treated with TM, TG, PBA and TUDCA for 24 h at 37°C at the concentrations listed below.

### HLEC morphological analysis

SRA01/04 cells were treated with 0.01 µM TG or a combination of 0.01 µM TG and 0.25 mM PBA for 24 h. Untreated SRA01/04 cells served as the control group. Cell morphology was analyzed under an inverted phase-contrast microscope (Axiovert 200; Carl Zeiss AG), and images were captured using a digital camera (AxioCam HRC; Carl Zeiss AG; magnification ×20). A minimum of 9 images per group were analyzed using ImageJ software 1.8.0 (National Institutes of Health) and the length of the long axis of the cells and the aspect ratio, defined as the ratio of the long axis (width) to the short axis (length) of the cells, were determined. The experiment was performed in triplicate.

### Western blot analysis

SRA01/04 cells were treated with 0.01 µM TG, 0.01 µM TG and 0.25 mM PBA, 0.01 µM TG and 2 mM TUDCA, 0.1 µM TM, 0.1 µM TM and 0.25 mM PBA or 0.1 µM TM and 2 mM TUDCA for 24 h. Untreated and DMSO-treated SRA01/04 cells served as the control groups. Total protein was subsequently extracted from the cells using radioimmunoprecipitation assay buffer. Protein samples (30 µg protein/lane) were separated via SDS-PAGE on a 12% gel. The separated proteins were subsequently transferred onto a polyvinylidene fluoride membrane and blocked for 90 min with 5% skim milk in TBST (0.05% Tween) at room temperature. The membrane was incubated with primary antibodies against GRP78, ATF6, ATF4, P-eIF2α, P-IRE1α, fibronectin, vimentin, α-SMA, N-cadherin, E-cadherin and β-actin (all 1:1,000) overnight at 4°C. Following the primary incubation, membranes were incubated with horseradish peroxidase-conjugated horse anti-mouse or horse anti-rabbit secondary antibodies at room temperature for 90 min. The membrane was then incubated with enhanced chemiluminescence substrates (ECL-WBKLS0100; EMD Millipore) at room temperature for 2 min and the protein bands were visualized using a ChemiDoc XRS+ imager. Protein expression was quantified using Image Lab software (Imagelab 4.0) with β-actin as the loading control.

### Immunofluorescence analysis

SRA01/04 cells were treated as aforementioned in the previous paragraph (western blot analysis) and 4×10^5^ cells were seeded onto cover slips in a 12-well plate and cultured for 24 h. Cells were subsequently fixed with ice-cold acetone for 15 min, permeabilized with 0.5% Triton X-100 for 5 min and blocked with 1% bovine serum albumin in PBS for 90 min at room temperature. The cells were incubated with primary antibodies against fibronectin, vimentin, α-SMA and N-cadherin (all 1:200) overnight at 4°C. Subsequently, the cells were washed with PBS containing 0.1% Tween-20 at room temperature and then incubated with Alexa Fluor 488-conjugated goat anti-rabbit or Alexa Fluor 488-conjugated goat anti-mouse secondary antibodies (1:5,000) at room temperature for 90 min. VECTASHIELD Mounting Medium with DAPI (H1200, Vector Laboratories, Inc.) was used for DAPI staining at room temperature. Cells were observed under a fluorescence microscope (AX70; Olympus Corporation; magnification, ×20). The relative fluorescence intensity of the specific proteins was quantified in 5 randomly-selected fields using ImageJ software 1.8.0 (National Institutes of Health), and normalized to the total number of cells. Data from 3 images per group were used for statistical analysis.

### Wound-healing assay

A wound-healing assay was performed to assess the migration ability of SRA01/04 cells under specific ER stress conditions. A serum starving method was used for minimizing cell proliferation in the wound-healing assay. Dulbecco\'s Modified Eagle Medium supplemented with 0.5% fetal bovine serum and 1% penicillin/streptomycin was used for culturing the cells at 37°C. The cells were treated with 0.01 µM TG, 0.1 µM TM, 0.01 µM TG and 0.25 mM or 0.1 µM TM and 0.25 mM PBA for 24 h. Untreated and DMSO-treated SRA01/04 cells served as the control groups. Sterilized pipette tips were used to create a wound across the confluent cell monolayer, and debris was removed with PBS. Migration of the cells into the wound was observed after 24 h in 5 randomly-selected fields under an inverted phase-contrast microscope at magnification, ×40. Cell migration was analyzed using ImageJ software (National Institutes of Health) and was expressed as the repair rate of scarification, defined as the percentage of the gap relative to the total area of the cell-free region immediately following wounding. Experiments were performed in triplicate at least 3 times.

### Statistical analysis

The results are expressed as the mean ± standard deviation of at least 3 independent experiments. Statistical analysis was performed using GraphPad Prism software (v7; GraphPad Software, Inc.). A one-way analysis of variance followed by Tukey\'s post hoc test was used to compare the different groups. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### HLEC morphology is altered following prolonged ER stress

In order to investigate the effect of ER stress on cell morphology and alignment, SRA01/04 cells were treated with DMSO, TG and a combination of TG and PBA. Representative images of SRA01/04 cells from each treatment group are presented in [Fig. 1A](#f1-mmr-21-01-0173){ref-type="fig"}. Compared with the other groups, TG-treated cells had a spindle-like appearance and an elongated long axis ([Fig. 1B](#f1-mmr-21-01-0173){ref-type="fig"}). The results indicated that activation of ER stress by TG had a significant effect on SRA01/04 cell elongation, and that this effect was eliminated by the ER stress inhibitor PBA. The morphology of TG-treated cells resembled that of fiber cells rather than epithelial cells.

### TM and TG trigger ER stress in HLECs

The present study revealed that TG altered the morphology of SRA01/04 cells and that this effect was inhibited by PBA. ER stress following treatment with TM, TG, PBA or TUDCA was subsequently investigated. Western blot analysis was performed to determine the levels of proteins associated with 3 pathways of the UPR. The expression levels of GRP78, p-eIf2α, ATF6, ATF4 and P-IRE1α expression in SRA01/04 cells were significantly increased following treatment with TM or TG and significantly decreased following treatment PBA or TUDCA ([Fig. 1C and D](#f1-mmr-21-01-0173){ref-type="fig"}). The results suggested that ER stress was triggered by TM or TG and inhibited by PBA or TUDCA.

### ER stress facilitates EMT in HLECs

To address the effect of ER stress on EMT, SRA01/04 cells were exposed to the classic ER stress inducers TM or TG alone or in combination with classic ER stress inhibitors PBA or TUDCA for 24 h. The expression of fibronectin, vimentin, α-SMA, N-cadherin, E-cadherin and β-actin was measured by western blot analysis. Compared with the control groups, N-cadherin, vimentin, α-SMA and fibronectin protein levels in TM-treated cells were increased by 1.82-, 1.76-, 2.18- and 2.69-fold, respectively. Furthermore, the protein level of E-cadherin decreased to 37% of the control groups ([Fig. 2A](#f2-mmr-21-01-0173){ref-type="fig"}). Compared with the control groups, N-cadherin, vimentin, α-SMA and fibronectin protein levels in TG-treated cells were increased by 2.21-, 1.66-, 2.49- and 1.86-fold. Furthermore, the protein level of E-cadherin had decreased by 0.61-fold ([Fig. 2B](#f2-mmr-21-01-0173){ref-type="fig"}). By contrast, SRA01/04 cells treated with a combination of PBA or TUDCA and TM or TG did not exhibit significant changes in the expression of the aforementioned EMT-associated proteins compared with the control groups ([Fig. 2A and B](#f2-mmr-21-01-0173){ref-type="fig"}). These results indicated that ER stress triggered EMT in SRA01/04 cells, and immunofluorescence staining was performed to corroborate these results. As expected, the average fluorescence intensities corresponding to fibronectin, vimentin, α-SMA and N-cadherin per cell were significantly increased in the TM- and TG-treated groups compared with the control groups ([Fig. 3](#f3-mmr-21-01-0173){ref-type="fig"}). Furthermore, the increased expression was attenuated in cells treated with a combination of TM and TUDCA or TG and TUDCA.

### ER stress enhances migration of HLECs

The wound-healing assay revealed that ER stress promoted the migration of SRA01/04 cells ([Fig. 4A and B](#f4-mmr-21-01-0173){ref-type="fig"}). The migration of SRA01/04 cells was significantly increased in TM- or TG-treated cells compared with the untreated control group. The repair rate of scarification of the TM- and TG-treated cells after 24 h was 60 and 65%, respectively. However, cells treated with a combination of TM and PBA or TG and PBA did not exhibit a significant difference in the repair rate of scarification compared with the control group. The DMSO-treated cells served as the negative control. No significant differences were observed between the DMSO-treated cells and the untreated cells.

Discussion
==========

The present study investigated the role of ER stress on EMT in HLECs. ER stress triggers a response termed the UPR, which serves to decrease cell stress ([@b17-mmr-21-01-0173]). The UPR is activated following cellular stress in several disorders, including cataracts ([@b18-mmr-21-01-0173]). A previous study revealed that ER stress and the UPR participate in the formation of several types of cataracts ([@b19-mmr-21-01-0173]). In the present study, TM and TG were used to activate the UPR, and PBA and TUDCA were used to inhibit its activation. TM- or TG-treated SRA01/04 cells exhibited increased GRP78, p-eIf2α, ATF6, ATF4 and P-IRE1α expression levels compared with the control groups, indicating that 3 UPR pathways were activated. Conversely, treatment with PBA or TUDCA decreased the expression of these proteins. The results obtained in the present study are in concordance with the well-known effects of TM, TG, PBA and TUDCA on HLECs.

During EMT, epithelial cancer cells lose polarity and cell-cell adhesion while gaining a more mesenchymal and invasive phenotype. Additionally, the cells appear to adopt a fibroblastic spindle-like morphology ([@b7-mmr-21-01-0173],[@b20-mmr-21-01-0173]). The present study revealed that SRA01/04 cells exhibited a more spindle-like morphology following treatment with TG. Additionally, the long axis of the cells was significantly elongated compared with the control group.

The present study subsequently investigated whether chemically-induced ER stress may have an effect on EMT in SRA01/04 cells. Typical markers for EMT include the downregulation of E-cadherin and the upregulation of N-cadherin, vimentin, fibronectin and α-SMA ([@b21-mmr-21-01-0173]). Previous studies revealed that ER stress and EMT markers are commonly observed under stress conditions in multiple tissues, including the lungs, liver and kidneys ([@b22-mmr-21-01-0173]--[@b26-mmr-21-01-0173]). The western blot analysis and immunofluorescence staining performed in the present study revealed a decreased expression level of E-cadherin and increased expression levels of N-cadherin, vimentin, fibronectin and α-SMA in TM- or TG-treated SRA01/04 cells compared with the controls. However, these changes in expression were not significant when the disruption of ER stress was inhibited by TUDCA or PBA, suggesting that ER stress may serve regulatory role in EMT.

Cataract surgery is an effective treatment strategy; however, it is not possible to completely remove the lens epithelial cells attached to an intact lens capsule. A number of previously published studies suggested that EMT is implicated in the pathogenesis of fibrotic posterior capsular opacification (PCO) ([@b27-mmr-21-01-0173],[@b28-mmr-21-01-0173]). Therefore, an increased understanding of how cataract surgery initiates EMT and how to modulate EMT following cataract surgery is required. The present study investigated the migration of SRA01/04 cells under conditions that regulate ER stress. The results revealed that TM- or TG-treated cells exhibited enhanced migration compared with the control groups, an effect that was abrogated in the presence of TUDCA or PBA.

In summary, the results from the present study suggested that ER stress is an important regulator of EMT in HLECs. Therefore, suppressing ER stress and regulating the EMT may serve as a novel therapeutic strategy to reduce PCO following cataract surgery.
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![SRA01/04 cells treated with endoplasmic reticulum stress inducers exhibit a morphological change, from an epithelial- to a fibroblast-like morphology. SRA01/04 cells were treated with 0.01 µM TG or a combination of 0.01 µM TG and 0.25 mM PBA for 24 h. Untreated SRA01/04 cells served as the control group. (A) Micrographs were obtained under an inverted phase-contrast microscope (magnification, ×20). The red arrows indicate that TG-treated cells had a spindle-like appearance and an elongated long axis. (B) The cellular aspect ratio was analyzed with ImageJ software (n=3). \*P\<0.05 vs. control. SRA01/04 cells were treated with 0.01 µM TG, 0.01 µM TG and 0.25 mM PBA, 0.01 µM TG and 2 mM TUDCA, 0.1 µM TM, 0.1 µM TM and 0.25 mM PBA or 0.1 µM TM and 2 mM TUDCA for 24 h. (C) ER stress markers were determined by western blot analysis. (D) The expression levels of GRP78, p-IRE1α, p-eIF2α, ATF4 and ATF6 were quantified by densitometry (n=3). \*P\<0.05 vs. control. TG, thapsigargin; TM, tunicamycin; PBA, 4-phenylbutyric acid; TUDCA, tauroursodeoxycholate; GRP78, glucose-regulated protein 78 kDa; P-IRE1α, phosphorylated inositol-requiring protein 1α; P-eIf2α, phosphorylated eukaryotic initiation factor 2α; ATF6, activating transcription factor 6; ATF4, activating transcription factor 4; DMSO, dimethyl sulfoxide; Con, control.](MMR-21-01-0173-g00){#f1-mmr-21-01-0173}

![Enhanced endoplasmic reticulum stress upregulates EMT-associated protein expression and downregulates epithelial marker expression. (A) SRA01/04 cells were treated with 0.1 µM TM, 0.1 µM TM and 0.25 mM PBA or 0.1 µM TM and 2 mM TUDCA for 24 h. (B) SRA01/04 cells were treated with 0.01 µM TG, 0.01 µM TG and 0.25 mM PBA or 0.01 µM TG and 2 mM TUDCA for 24 h. The expression levels of the EMT-associated markers fibronectin, vimentin, α-SMA, N-cadherin and E-cadherin were measured by western blot analysis (n=3). \*P\<0.05 vs. control. EMT, epithelial-to-mesenchymal transition; TG, thapsigargin; TM, tunicamycin; PBA, 4-phenylbutyric acid; TUDCA, tauroursodeoxycholate; α-SMA, α-smooth muscle actin. N-cadherin, neural cadherin; E-cadherin, epithelial cadherin; DMSO, dimethyl sulfoxide; Con, control.](MMR-21-01-0173-g01){#f2-mmr-21-01-0173}

![Immunofluorescence analysis of endoplasmic reticulum stress-induced expression of vimentin, N-cadherin, α-SMA and fibronectin in SRA01/04 cells. SRA01/04 cells were treated with 0.01 µM TG, 0.01 µM TG and 0.25 mM PBA, 0.01 µM TG and 2 mM TUDCA, 0.1 µM TM, 0.1 µM TM and 0.25 mM PBA or 0.1 µM TM and 2 mM TUDCA for 24 h. The expression of (B) vimentin, (D) N-cadherin, (F) α-SMA and (H) fibronectin was determined by immunofluorescence analysis. The average fluorescence of (A) vimentin, (C) N-cadherin, (E) α-SMA and (G) fibronectin was quantified (n=3). \*P\<0.05 vs. control, magnification, ×20. α-SMA, α-smooth muscle actin; N-cadherin, neural cadherin; E-cadherin; epithelial cadherin; TG, thapsigargin; TM, tunicamycin; PBA, 4-phenylbutyric acid; TUDCA, tauroursodeoxycholate.](MMR-21-01-0173-g02){#f3-mmr-21-01-0173}

![Endoplasmic reticulum stress facilitates the cell migration of SRA01/04 cells. SRA01/04 cells were treated with 0.01 µM TG, 0.1 µM TM, 0.01 µM TG and 0.25 mM or 0.1 µM TM and 0.25 mM PBA for 24 h and were subsequently subjected to a wound healing assay. Untreated and dimethyl sulfoxide-treated SRA01/04 cells served as the control groups. (A) Cells that migrated into the wounded area from the border of the wound after 24 h were visualized and images were captured under an inverted phase-contrast microscope (magnification, ×10). (B) Cell migration was used to calculate the repair rate of scarification, expressed as the percentage of the gap relative to the total area of the cell-free region, using ImageJ software (n=3). \*P\<0.05 vs. control. TG, thapsigargin; TM, tunicamycin; PBA, 4-phenylbutyric acid; TUDCA, tauroursodeoxycholate; α-SMA, α-smooth muscle actin; DMSO, dimethyl sulfoxide; Con, control.](MMR-21-01-0173-g03){#f4-mmr-21-01-0173}
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